[1] 赵彬, 刘斌, 张玉芹, 等. 依达拉奉对脑出血大鼠血肿周围组织Caspase3和Pdcd5蛋白表达的影响[J]. 天津医药, 2012, 40(5):483485.
[2] Tracy CM, Gray AJ, Cuéllar J, et al. Programmed cell death protein 5 interacts with the cytosolic chaperonin containing tailless complex polypeptide 1 (CCT) to regulate βtubulin folding[J]. J Biol Chem, 2014, 289(7):4490502.
[3] 赵青, 张明川, 梅同华. 促凋亡基因程序化死亡因子5在非小细胞肺癌中的表达及意义[J].重庆医科大学学报, 2013, 38(8):868871.
[4] Xu S, Sui G, Yuan L, et al. Expression of programmed cell death 5 protein inhibits progression of lung carcinoma in vitro and in vivo via the mitochondrial apoptotic pathway[J]. Mol Med Rep, 2014, 10(4):20592064.
[5] 张婧雯, 蒋军广, 翟展艺, 等. 凋亡相关基因PDCD5在非小细胞肺癌中的表达及临床意义[J]. 中国老年学杂志, 2013, 33(5):20062008.
[6] Fan GL, Yao Y, Yao L, et al. PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells[J]. Oncol Lett, 2015, 9(1):411417.
[7] Gao F, Ding L, Zhao M, et al. The clinical significance of reduced programmed cell death 5 expression in human gastrointestinal stromal tumors[J]. Oncol Rep, 2012, 28(6):21952199.
[8] Xu HY, Chen ZW, Pan YM, et al. Transfection of PDCD5 effect on the biological behavior of tumor cells and sensitized gastric cancer cells to cisplatininduced apoptosis[J]. Dig Dis Sci, 2012, 57(7):18471856.
[9] 郑湘予, 吴成富, 崔黎, 等. 白藜芦醇对裸鼠胃癌移植瘤中PDCD5蛋白表达及细胞凋亡的影响[J]. 疑难病杂志, 2012, 11(8):611613.
[10] Xu F, Wu K ,Zhao M, et al. Expression and clinical significance of the programmed cell death 5 gene and protein in laryngeal squamous cell carcinoma[J]. J Int Med Res, 2013, 41(6):18381847.
[11] Zhang X, Wang X, Song X. Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas[J]. Oncol Rep, 2011, 25(2):353358.
[12] Wang L, Wang C, Su B, et al. Recombinant human PDCD5 protein enhances chemosensitivity of breast cancer in vitro and in vivo[J]. Biochem Cell Biol, 2013, 91(6):526531.
[13] Li H, Zhang X, Song X, et al. PDCD5 promotes cisplatininduced apoptosis of glioma cells via activating mitochondrial apoptotic pathway[J]. Cancer Biol Ther, 2012, 13(9):822830.
[14] Han XR, Sun Y, Bai XZ, et al. The antitumor role and mechanism of integrated and truncated PDCD5 proteins in osteosarcoma cells[J]. Cell Signal, 2012, 24(8):17131721.
[15] Lu H, Wang C, Hao L, et al. The expression and significance of programmed cell death 5 and Bcelllymphoma/lewkmia2 in sinonasal squamous cell carcinoma[J]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2014, 28(17):13011304.
[16] Murshed F, FarhanaL, Dawson MI, et al. NFκB p65 recruited SHP regulates PDCD5mediated apoptosis in cancer cells[J]. Apoptosis, 2014, 19(3):506517.
[17] Xiao J, Liu C, Li G, et al. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses[J]. J Autoimmun, 2013, 47:3444.
[18] Xu L, Hu J, Zhao Y, et al. PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway[J]. Apoptosis, 2012, 17(11):12351245. |